A case of omental endometriosis complicated by hemorrhagic ascites leading to pelvic encapsulated effusion Authors: Shuo Cao, Tao Zhang Published: 2026 ABSTRACT BackgroundEndometriosis is an estrogen-dependent benign inflammatory disorder characterized by the implantation of active endometrial tissue (glands or stroma) outside the uterus, with pelvic adhesions as a core hallmark. Omental endometriosis is an extremely rare subtype of extra-pelvic endometriosis (accounting for < 5% of all extra-pelvic endometriosis cases), and its concurrent presentation with massive hemorrhagic ascites and de novo pelvic encapsulated effusion without predisposing factors (e.g., pelvic surgery, pelvic inflammatory disease) remains scarcely reported in existing clinical literature.Case presentationA 45-year-old premenopausal woman (gravida 4, para 2) presented with the chief complaint of increased menstrual flow and prolonged menstruation, without classic endometriosis symptoms such as dysmenorrhea or chronic pelvic pain and no history of abdominal/pelvic surgery or pelvic inflammatory disease. Examination revealed a significant amount of hemorrhagic ascites, pelvic encapsulated effusion, multiple omental nodules on abdominal CT, mildly elevated serum CA125 (85.51 IU/ml) with normal HE4 (61.22 pmol/L), and no malignant cells in ascitic cytology. The cause of hemorrhagic ascites was not definitively diagnosed preoperatively due to overlapping clinical and imaging features with malignant tumors; postoperative pathological and immunohistochemical findings confirmed omental endometriosis.ConclusionOmental endometriosis should be considered in premenopausal women presenting with unexplained hemorrhagic ascites and pelvic encapsulated effusion, even in the absence of classic endometriosis symptoms, prior pelvic surgery, or malignant cytology—particularly when serum CA125 is elevated but HE4 remains normal. This case broadens the recognized clinical spectrum of extra-pelvic endometriosis and highlights the value of comprehensive preoperative evaluation combined with individualized, fertility-sparing surgical management. Background Endometriosis refers to the estrogen-dependent benign inflammatory disease caused by the active endometrial tissue (glands or stroma) outside the uterus. Pelvic adhesions are one of its most significant characteristics [1]. Despite being a benign disease, endometriosis can lead to extensive infiltration appearing to be caused by tumor growth. Endometrium can invade any part of the body, with the reproductive organs and ovaries being predilection sites for endometriosis, in which about 12% of cases are patients with endometriosis occurring outside the reproductive organs. Predilection sites include the rectouterine excavation, vesicouterine space, thoracic cavity, brain, and skin. Particularly, endometriosis in the rectouterine excavation may invade the sigmoid colon and rectum, causing intestinal stenosis [2], and ureteral endometriosis can lead to obstruction and hydronephrosis [3]. A systematic review of existing literature shows that omental endometriosis is an extremely rare subtype of extra-pelvic endometriosis, accounting for less than 5% of all extra-pelvic endometriosis cases [4, 5]. As a non-predilection site for endometrial implantation, the pathogenesis of omental endometriosis remains controversial, with two main proposed mechanisms: retrograde menstruation combined with peritoneal implantation and lymphatic/hematogenous dissemination, and metaplasia of omental mesothelial cells into endometrial tissue under estrogen and chronic inflammatory stimulation [6]. Most reported cases of omental endometriosis are accompanied by classic pelvic endometriosis symptoms (dysmenorrhea, chronic pelvic pain) or a history of pelvic disease/surgery, and isolated omental endometriosis with only menstrual abnormalities as the initial symptom is extremely rare [5]. A review of the literature revealed that endometriosis extending to the omentum has been rarely reported, and its presentation with concurrent massive hemorrhagic ascites and de novo pelvic encapsulated effusion has not been well-documented. This case report describes this rare clinical presentation of omental endometriosis, aiming to highlight its diagnostic challenges, expand the clinical spectrum of the disease, and emphasize the importance of including omental endometriosis in the differential diagnosis of unexplained ascites. Endometriosis is a histologically benign but behaviorally malignant disease, characterized by the potential for malignant transformation, with a malignancy rate of about 1% and the ovary being the most common site for such transformation [7]. In the meantime, malignant transformation of endometriosis at sites of cesarean scar has also been reported [8]. Case presentation The patient is a 45-year-old woman, gravida 4, para 2, with regular menstrual cycles of 30/4 days. She presented to our hospital 1 year ago with prolonged menstruation to 15 days, with increased menstrual flow about twice the usual amount, accompanied by dull pain in the lower abdomen, without a history of dysmenorrhea, chronic pelvic pain, abdominal/pelvic surgery, pelvic inflammatory disease or pelvic tuberculosis. Examination upon admission Normal vulva, smooth cervix, no tenderness, anterior uterus enlarged to the size of a 15-week gestation, uneven surface, fair activity, and mild tenderness. A mass was palpable in the pelvic cavity, with poorly defined borders and positive shifting dullness. Key laboratory examination results of the patient are summarized in Table 1; routine blood tests, infection panel, hormone levels, and coagulation tests showed no significant abnormalities, with elevated serum carbohydrate antigen CA125 (CA125: 85.51 IU/ml) and normal human epididymis secretory protein 4 (HE4: 61.22 pmol/L). Tuberculin skin test and quantitative T-cell testing for tuberculosis (negative). Ultrasound findings (Fig. 1): Multiple uterine fibroids, with the largest being about 5.1 cm in diameter; hydrosalpinx in the left fallopian tube; encapsulated effusion surrounding the uterus and right ovary, with a maximum depth of 5.1 cm; and free effusion in the abdominal cavity, with a maximum depth of about 8 cm. Further examinations via upper abdominal CT (Fig. 2): Abdominal effusion and increased density of the omentum with multiple small nodular shadows. Pelvic MRI (Fig. 3): Uterine fibroids; bilateral hydrosalpinx; localized fluid signal in the pelvic cavity with multiple septations, suggesting a cystic mass in the right adnexa; abdominopelvic effusion; diffusion-weighted imaging (DWI) was not performed considering the clear display of anatomical structure and effusion by conventional MRI sequences. The patient underwent paracentesis on Day 3 of admission for the drainage of red fluid. Pathological findings of ascites: Numerous red blood cells, few mesothelial cells, and no tumor cells. Table 1Laboratory examination results of the patientExamination IndexTest ResultReference RangeWBC (×10⁹/L)6.23.5–9.5Hb (g/L)118110–150Platelet (×10⁹/L)235100–300CA125 (IU/ml)85.51< 35.0HE4 (pmol/L)61.22< 140.0E2 (pg/ml)45.325–309 (premenopausal)Progesterone (ng/ml)1.20.2–1.5 (follicular phase)PT (s)11.510–13APTT (s)32.625–38 Table 1Laboratory examination results of the patientExamination IndexTest ResultReference RangeWBC (×10⁹/L)6.23.5–9.5Hb (g/L)118110–150Platelet (×10⁹/L)235100–300CA125 (IU/ml)85.51< 35.0HE4 (pmol/L)61.22< 140.0E2 (pg/ml)45.325–309 (premenopausal)Progesterone (ng/ml)1.20.2–1.5 (follicular phase)PT (s)11.510–13APTT (s)32.625–38 Laboratory examination results of the patient Fig. 1Pelvic ultrasound: M indicates multiple uterine fibroids, with encapsulated effusion around the uterus and right ovary Pelvic ultrasound: M indicates multiple uterine fibroids, with encapsulated effusion around the uterus and right ovary Fig. 2Upper abdominal CT: The arrow indicates increased omental density with multiple small nodular shadows Upper abdominal CT: The arrow indicates increased omental density with multiple small nodular shadows Fig. 3Pelvic MRI: localized fluid signal in the pelvic cavity with multiple septations, and cystic mass in right adnexa? (red arrow), Uterine fibroids, hydrosalpinx (black arrow) Pelvic MRI: localized fluid signal in the pelvic cavity with multiple septations, and cystic mass in right adnexa? (red arrow), Uterine fibroids, hydrosalpinx (black arrow) Afterward, the patient underwent exploratory laparotomy on Day 15 of admission. Intraoperative findings: About 200 ml of dark red ascites, the uterus enlarged to the size of a 15-week gestation, uneven surface with multiple muscular nodules of varying sizes, uterine adhesions making it fixed and difficult to lift, adhesions in the intestinal canal, bilateral adnexal area wrapped in adhesions with no obvious abnormal lesions in the bilateral ovaries (preserved intraoperatively), and hard and cake-like terminal omentum with a diameter of 7–8 cm. Preoperative fertility preservation was fully discussed with the patient, who clearly expressed no fertility requirements due to her age (45 years old) and reproductive history (gravida 4, para 2). Total hysterectomy + bilateral salpingectomy + pelvic adhesiolysis + intestinal adhesiolysis + partial omentectomy were performed. Provisional clinical diagnosis Based on the clinical presentation, pelvic examination, and ultrasound findings, the patient was provisionally diagnosed with:Multiple uterine leiomyomas;Pelvic encapsulated effusion;Abdominopelvic free effusion (suspected hemorrhagic);Left hydrosalpinx. Multiple uterine leiomyomas; Multiple uterine leiomyomas; Pelvic encapsulated effusion; Pelvic encapsulated effusion; Abdominopelvic free effusion (suspected hemorrhagic); Abdominopelvic free effusion (suspected hemorrhagic); Left hydrosalpinx. Left hydrosalpinx. Differential diagnosis Given the rarity of hemorrhagic ascites in reproductive-aged women, systematic differential diagnosis was performed to rule out the following conditions:Malignancy: Ovarian cancer, peritoneal carcinomatosis, and malignant transformation of endometriosis were considered due to elevated CA125 (85.51 IU/ml) and omental nodules on CT. However, normal HE4 levels (61.22 pmol/L, a marker with high specificity for ovarian cancer) and negative ascitic cytopathology (no tumor cells) mitigated malignancy suspicion. Intraoperative and postoperative pathology confirmed benign lesions, excluding malignant diseases.Pelvic Tuberculosis: Tuberculous ascites can mimic hemorrhagic effusion. TB skin test and quantitative T-cell testing for tuberculosis were negative, ruling out pelvic tuberculosis.Organ Dysfunction: Liver or kidney disease-induced ascites was excluded by normal routine blood tests, liver function, and renal function results.Meigs’ Syndrome: Excluded as ultrasound and MRI did not identify benign ovarian tumors (a core feature of Meigs’ syndrome).Pelvic Inflammatory Disease (PID): Ruled out due to absence of fever, leukocytosis, or severe pelvic tenderness, and normal infection panel results. Malignancy: Ovarian cancer, peritoneal carcinomatosis, and malignant transformation of endometriosis were considered due to elevated CA125 (85.51 IU/ml) and omental nodules on CT. However, normal HE4 levels (61.22 pmol/L, a marker with high specificity for ovarian cancer) and negative ascitic cytopathology (no tumor cells) mitigated malignancy suspicion. Intraoperative and postoperative pathology confirmed benign lesions, excluding malignant diseases. Malignancy: Ovarian cancer, peritoneal carcinomatosis, and malignant transformation of endometriosis were considered due to elevated CA125 (85.51 IU/ml) and omental nodules on CT. However, normal HE4 levels (61.22 pmol/L, a marker with high specificity for ovarian cancer) and negative ascitic cytopathology (no tumor cells) mitigated malignancy suspicion. Intraoperative and postoperative pathology confirmed benign lesions, excluding malignant diseases. Pelvic Tuberculosis: Tuberculous ascites can mimic hemorrhagic effusion. TB skin test and quantitative T-cell testing for tuberculosis were negative, ruling out pelvic tuberculosis. Pelvic Tuberculosis: Tuberculous ascites can mimic hemorrhagic effusion. TB skin test and quantitative T-cell testing for tuberculosis were negative, ruling out pelvic tuberculosis. Organ Dysfunction: Liver or kidney disease-induced ascites was excluded by normal routine blood tests, liver function, and renal function results. Organ Dysfunction: Liver or kidney disease-induced ascites was excluded by normal routine blood tests, liver function, and renal function results. Meigs’ Syndrome: Excluded as ultrasound and MRI did not identify benign ovarian tumors (a core feature of Meigs’ syndrome). Meigs’ Syndrome: Excluded as ultrasound and MRI did not identify benign ovarian tumors (a core feature of Meigs’ syndrome). Pelvic Inflammatory Disease (PID): Ruled out due to absence of fever, leukocytosis, or severe pelvic tenderness, and normal infection panel results. Pelvic Inflammatory Disease (PID): Ruled out due to absence of fever, leukocytosis, or severe pelvic tenderness, and normal infection panel results. Postoperative Routine Pathology Multiple uterine leiomyomas, multiple peritoneal-containing cysts on the serosal surface of the uterus, secretory endometrium, and chronic cervicitis. Chronic inflammation of bilateral tubal mucosa.Omental endometriosis (Fig. 4)(Omentum majus HE) Endometrioid glands and endometrioid stroma are seen within the adipose tissue. Combined with morphological features and immunohistochemical results, the lesion is consistent with endometriosis(200*200); (3)immunohistochemistry assay (Fig. 5): ER (+), PR (+), Ki-67 (5%), P53 (focal weak positive, suggestive of wild-type), PAX-8 (+), CK7 (+), CK20 (-) ༈200*200༉. Cytological examination of ascites suggested no cancer cells. Multiple uterine leiomyomas, multiple peritoneal-containing cysts on the serosal surface of the uterus, secretory endometrium, and chronic cervicitis. Chronic inflammation of bilateral tubal mucosa. Multiple uterine leiomyomas, multiple peritoneal-containing cysts on the serosal surface of the uterus, secretory endometrium, and chronic cervicitis. Chronic inflammation of bilateral tubal mucosa. Omental endometriosis (Fig. 4)(Omentum majus HE) Endometrioid glands and endometrioid stroma are seen within the adipose tissue. Combined with morphological features and immunohistochemical results, the lesion is consistent with endometriosis(200*200); (3)immunohistochemistry assay (Fig. 5): ER (+), PR (+), Ki-67 (5%), P53 (focal weak positive, suggestive of wild-type), PAX-8 (+), CK7 (+), CK20 (-) ༈200*200༉. Cytological examination of ascites suggested no cancer cells. Omental endometriosis (Fig. 4)(Omentum majus HE) Endometrioid glands and endometrioid stroma are seen within the adipose tissue. Combined with morphological features and immunohistochemical results, the lesion is consistent with endometriosis(200*200); (3)immunohistochemistry assay (Fig. 5): ER (+), PR (+), Ki-67 (5%), P53 (focal weak positive, suggestive of wild-type), PAX-8 (+), CK7 (+), CK20 (-) ༈200*200༉. Cytological examination of ascites suggested no cancer cells. Fig. 4Pathology: (Omentum majus) Endometrioid glands and endometrioid stroma are seen within the adipose tissue. Combined with morphological features and immunohistochemical results, the lesion is consistent with endometriosis(HE 200*200) Pathology: (Omentum majus) Endometrioid glands and endometrioid stroma are seen within the adipose tissue. Combined with morphological features and immunohistochemical results, the lesion is consistent with endometriosis(HE 200*200) Fig. 5Immunohistochemistry: ER (+), PR (+), Ki-67 (5%), P53 (focal weak positive, suggestive of wild-type), PAX-8 (+), CK7 (+), CK20 (-) (200*200) Immunohistochemistry: ER (+), PR (+), Ki-67 (5%), P53 (focal weak positive, suggestive of wild-type), PAX-8 (+), CK7 (+), CK20 (-) (200*200) The patient was followed up for 12 months postoperatively, with no recurrence of ascites observed upon re-examination via ultrasound. Discussion To accurately position our case within the existing clinical landscape, we conducted a comprehensive literature review focusing on cases of omental endometriosis associated with hemorrhagic ascites. A structured search in PubMed/MEDLINE was performed for English-language case reports published between 2000 and 2025, using the keywords “omental endometriosis,” “hemorrhagic ascites,” and “pelvic encapsulated effusion.” Cases were included if they provided sufficient clinical, laboratory, imaging, and treatment details. The key characteristics of previously reported, clinically relevant cases are summarized and compared with our case in Table 2. Table 2Comparative Summary of Reported Cases of Omental Endometriosis with Hemorrhagic AscitesFeaturePreviously Reported Typical Cases (e.g., [Ref 5, 6, 10])Our Case (Zhang & Cao, 2025)Unique Contribution of This CaseChief Complaint & Classic SymptomsOften present with classic pelvic endometriosis symptoms: dysmenorrhea, chronic pelvic pain, or infertility.Atypical: Increased menstrual flow, prolonged menstruation, and mild lower abdominal dull pain. No dysmenorrhea or chronic pelvic pain.Expands the clinical phenotype; demonstrates that omental endometriosis can manifest with isolated menstrual abnormalities, mimicking primary uterine pathology like leiomyomas.History of Predisposing FactorsFrequently reported with a history of prior pelvic/abdominal surgery, known endometriosis, or pelvic inflammatory disease.No predisposing factors: No history of prior surgery, PID, or known endometriosis.Highlights a de novo mechanism of pelvic adhesions and encapsulated effusion directly triggered by peritoneal irritation from omental lesions.Key Imaging FindingsOmental “caking” or nodules, ascites; often a high suspicion of malignancy.Omental caking with concurrent, de novo pelvic encapsulated effusion (clearly shown on ultrasound and MRI) without prior surgical or infectious cause.First to explicitly describe and analyze this dual-finding (omental caking + de novo encapsulated effusion) as presenting features, creating a specific high-risk mimic of ovarian cancer.Preoperative DiagnosisAccurate preoperative diagnosis is rare (< 30%); often exploratory surgery for suspected malignancy.Diagnostic dilemma: Preoperative suspicion was multiple leiomyomas and unexplained ascites; malignancy was the leading concern due to CA125 and omental caking.Reinforces diagnostic challenge in the absence of classic symptoms. The triad of (1) normal HE4, (2) absent malignancy cells in ascites, and (3) normal ovaries on ultrasound is a key pre-operative clue.Primary Treatment & Follow-upVariable; often includes adnexal surgery. Long-term follow-up data is limited.Fertility-sparing adnexal management: Total hysterectomy and bilateral salpingectomy were for symptomatic leiomyomas, but bilateral ovaries were preserved after careful intraoperative evaluation. 12-month recurrence-free follow-up was achieved.Supports individualized, conservative adnexal management in premenopausal women when ovaries are normal, avoiding unnecessary oophorectomy. Provides documented 1-year outcome data.Abbreviations: PID Pelvic Inflammatory Disease, CA125 Cancer Antigen 125, HE4 Human Epididymis Protein 4 Table 2Comparative Summary of Reported Cases of Omental Endometriosis with Hemorrhagic AscitesFeaturePreviously Reported Typical Cases (e.g., [Ref 5, 6, 10])Our Case (Zhang & Cao, 2025)Unique Contribution of This CaseChief Complaint & Classic SymptomsOften present with classic pelvic endometriosis symptoms: dysmenorrhea, chronic pelvic pain, or infertility.Atypical: Increased menstrual flow, prolonged menstruation, and mild lower abdominal dull pain. No dysmenorrhea or chronic pelvic pain.Expands the clinical phenotype; demonstrates that omental endometriosis can manifest with isolated menstrual abnormalities, mimicking primary uterine pathology like leiomyomas.History of Predisposing FactorsFrequently reported with a history of prior pelvic/abdominal surgery, known endometriosis, or pelvic inflammatory disease.No predisposing factors: No history of prior surgery, PID, or known endometriosis.Highlights a de novo mechanism of pelvic adhesions and encapsulated effusion directly triggered by peritoneal irritation from omental lesions.Key Imaging FindingsOmental “caking” or nodules, ascites; often a high suspicion of malignancy.Omental caking with concurrent, de novo pelvic encapsulated effusion (clearly shown on ultrasound and MRI) without prior surgical or infectious cause.First to explicitly describe and analyze this dual-finding (omental caking + de novo encapsulated effusion) as presenting features, creating a specific high-risk mimic of ovarian cancer.Preoperative DiagnosisAccurate preoperative diagnosis is rare (< 30%); often exploratory surgery for suspected malignancy.Diagnostic dilemma: Preoperative suspicion was multiple leiomyomas and unexplained ascites; malignancy was the leading concern due to CA125 and omental caking.Reinforces diagnostic challenge in the absence of classic symptoms. The triad of (1) normal HE4, (2) absent malignancy cells in ascites, and (3) normal ovaries on ultrasound is a key pre-operative clue.Primary Treatment & Follow-upVariable; often includes adnexal surgery. Long-term follow-up data is limited.Fertility-sparing adnexal management: Total hysterectomy and bilateral salpingectomy were for symptomatic leiomyomas, but bilateral ovaries were preserved after careful intraoperative evaluation. 12-month recurrence-free follow-up was achieved.Supports individualized, conservative adnexal management in premenopausal women when ovaries are normal, avoiding unnecessary oophorectomy. Provides documented 1-year outcome data.Abbreviations: PID Pelvic Inflammatory Disease, CA125 Cancer Antigen 125, HE4 Human Epididymis Protein 4 Comparative Summary of Reported Cases of Omental Endometriosis with Hemorrhagic Ascites Abbreviations: PID Pelvic Inflammatory Disease, CA125 Cancer Antigen 125, HE4 Human Epididymis Protein 4 In this case, the patient presented with the chief complaint of increased menstrual flow and prolonged menstruation, without classic endometriosis symptoms, and a significant amount of hemorrhagic ascites was found during the examination, with ultrasound images indicating encapsulated effusion and abdominal CT suggesting multiple nodules in the omentum. The cause of the hemorrhagic ascites was not definitely diagnosed preoperatively, and postoperative pathological findings revealed omental endometriosis. This case is distinct from previously reported omental endometriosis cases in three core aspects: (1) Atypical initial symptom with only menstrual abnormalities and no classic pelvic endometriosis manifestations; (2) Concurrent massive hemorrhagic ascites and de novo pelvic encapsulated effusion without predisposing factors such as surgery or pelvic inflammatory disease, which is rarely documented in literature; (3) Diagnostic dilemma caused by elevated CA125 combined with omental caking, which highly mimics malignant tumors such as ovarian cancer [9–11]. The primary take-home message of this case is that endometriosis, particularly in extra-pelvic sites such as the omentum, can manifest as significant hemorrhagic ascites and should be included in the differential diagnosis even when classic symptoms of pelvic endometriosis are absent. This awareness is crucial to avoid misdiagnosis and delayed management, especially in women of reproductive age with unexplained ascites. Ectopic endometrial lesions in the omentum undergo cyclic proliferation and bleeding under estrogen stimulation, which directly induces local peritoneal irritation and the release of a large number of inflammatory factors (e.g., TNF-α, IL-6, VEGF) [12]. These inflammatory factors trigger persistent chronic peritoneal inflammation, leading to the activation and proliferation of peritoneal mesothelial cells and the formation of extensive pelvic adhesions—this is the core mechanism of pelvic encapsulated effusion formation in this patient without predisposing factors [13]. Meanwhile, reactive CA125 elevation is closely related to peritoneal irritation and chronic inflammation: CA125 is a glycoprotein mainly expressed on the surface of peritoneal mesothelial cells; activated mesothelial cells under inflammatory stimulation will overexpress and release CA125 into the blood, resulting in a mild to moderate increase in serum CA125 levels. In addition, the cyclic bleeding of omental endometriotic lesions can further damage the peritoneal barrier, exacerbating mesothelial cell activation and CA125 release [14]. This explains the mild elevation of CA125 and normal HE4 in this patient, which is a key serological feature distinguishing omental endometriosis from ovarian cancer. Imaging plays a pivotal role in the preoperative evaluation of suspected omental endometriosis. Ultrasonography typically reveals encapsulated effusion, septated cystic masses, and free fluid, as seen in our case. CT imaging often shows nonspecific nodular omental thickening or “omental caking,” which can mimic peritoneal carcinomatosis or tuberculosis. MRI, with its superior soft-tissue contrast, may demonstrate hemorrhagic or proteinaceous content within cystic lesions, along with adhesions and multifocal peritoneal implants. However, existing literature reports that the preoperative imaging diagnosis rate of omental endometriosis is less than 30% [5], as no single imaging modality has pathognomonic features for the disease. As illustrated here and supported by literature, imaging alone is seldom pathognomonic for omental endometriosis and often leads to diagnostic ambiguity, necessitating histopathological confirmation. Pelvic encapsulated effusion mostly occurs secondary to pelvic or abdominal surgeries, a history of pelvic tuberculosis, pelvic inflammatory disease, endometriosis, etc., the etiology of which remains unclear, with 82.3% of cases being secondary to surgery or pelvic inflammatory disease. Specifically, typical imaging findings of encapsulated effusion include: no capsule, no obvious borders, and cyst walls formed by fibrous cord tissue, intestinal canal, omentum, and internal reproductive organs, resulting in an irregular, unencapsulated, low-tension pelvic mass with fine septations, often containing a normal ovary (Figure.1). This patient had no prior history of abdominal surgery or chronic pelvic inflammatory disease, and the formation of pelvic encapsulated effusion was attributed to peritoneal irritation and chronic inflammation induced by omental endometriosis, which led to extensive adhesion of pelvic organs and the formation of a closed space for fluid accumulation—this de novo pathological mechanism is rarely reported in existing literature, further highlighting the novelty of this case. Despite the typical ultrasound images that clearly showed the right ovarian encapsulation, it was not reliable to diagnose encapsulated effusion by ultrasound alone. The mechanism of ascites caused by endometriosis remains unclear, and it has been proposed that free blood released from ruptured endometriotic cysts or endometrial cells stimulate the peritoneum to form ascites, or that ectopic lesions obstruct lymphatic drainage, leading to fluid accumulation [15–16]. The omentum is the main organ in maintaining peritoneal fluid balance, with a rich lymphatic and vascular network; omental endometriosis can directly damage the omental lymphatic drainage system, leading to impaired peritoneal fluid absorption and accumulation. In addition, cyclic bleeding of omental ectopic lesions and chronic peritoneal inflammation further increase peritoneal exudation, resulting in the rapid formation of hemorrhagic ascites, which is a characteristic feature of omental endometriosis-associated ascites [4, 6]. Additionally, hemorrhagic pleural effusion caused by thoracic endometriosis (TE) has also been reported [4]. Moreover, common differential diagnoses include ovarian cancer, peritoneal tuberculosis, liver and kidney diseases, Meigs’ syndrome, and special types of infections for female patients presenting with hemorrhagic ascites [6], with omental endometriosis being a rare cause, and a review of the literature found that most cases were similar to this patient and were diagnosed only after exploratory laparotomy or laparoscopy [5]. Therefore, in clinical practice, when encountering women of reproductive age with unexplained hemorrhagic ascites—especially those with elevated CA125 but no clear evidence of malignancy—clinicians should maintain a high index of suspicion for extra-pelvic endometriosis, including omental involvement. Furthermore, studies have indicated that serum CA125 levels may be elevated in patients with endometriosis [17], and this reactive elevation is usually mild to moderate (CA125 < 100 IU/ml) with normal HE4, which can be used as a key serological clue to distinguish from ovarian cancer, further complicating the diagnosis of clinicians and posing challenges for the treatment of patients. The surgical approach and scope for this patient were determined based on comprehensive preoperative evaluation and intraoperative findings, with the following core justifications: (1) Choice of exploratory laparotomy over laparoscopy: Preoperative imaging suggested severe pelvic adhesions and omental caking, and laparotomy can provide a clearer surgical field of vision and more thorough adhesiolysis, avoiding the risk of organ injury caused by laparoscopic operation under unclear vision; in addition, the preoperative diagnosis was ambiguous, and laparotomy is more conducive to frozen section examination if necessary. (2) Determination of surgical scope: Total hysterectomy was performed due to multiple uterine fibroids and increased menstrual flow (the patient’s main complaint); bilateral salpingectomy was performed to reduce the risk of tubal pregnancy and pelvic adhesion progression; partial omentectomy was the key to removing the omental endometriotic lesions and eliminating the source of peritoneal irritation and ascites; bilateral ovaries were preserved because no obvious abnormal lesions were found intraoperatively, and the patient was premenopausal (45 years old), which can avoid the adverse effects of premature ovarian failure on the patient’s endocrine function. (3) Adhesiolysis (pelvic + intestinal): Severe pelvic and intestinal adhesions are the main cause of pelvic encapsulated effusion, and thorough adhesiolysis is conducive to the recovery of pelvic organ function and the prevention of effusion recurrence. Following surgical resection, long-term management of omental endometriosis should address symptom control, prevention of recurrence, and surveillance for malignant transformation. Given the estrogen-dependent nature of the disease, hormonal suppression—such as with progestins, combined oral contraceptives, or GnRH agonists—may be considered, especially in premenopausal patients with residual or recurrent disease [18]. Although histopathology confirmed endometriosis and the ovaries were preserved, hormonal suppression was deferred for three reasons. First, the omental lesion was completely resected with clear margins, and no residual macroscopic disease was identified on the preserved ovaries or pelvic peritoneum. Second, the patient’s presenting symptoms—heavy and prolonged menstrual bleeding—were attributable to uterine leiomyomas and were definitively addressed by hysterectomy. Third, after thorough counseling on the benefits and potential adverse effects of hormonal therapy, the patient opted for a surveillance-first approach. Accordingly, a follow-up protocol comprising clinical examination, serum CA125 measurement, and pelvic ultrasound every 3–6 months was implemented. At 12 months, no recurrence was detected. Should recurrence develop, dienogest would be initiated promptly. Throughout follow-up, patient education on recurrence symptoms and the importance of regular gynecological review was emphasized, and multidisciplinary collaboration among gynecologists, radiologists, and pathologists was maintained to optimize outcomes. This case demonstrates several management strengths. First, the systematic preoperative workup—including CA125-HE4 discordance analysis, repeated ascitic cytology, and multimodal imaging—enabled a rational exclusion of malignancy and informed the decision to proceed with surgical exploration rather than oncological debulking. Second, the choice of laparotomy provided optimal visualization and safe adhesiolysis given the severe pelvic adhesions and omental caking, avoiding the risk of organ injury that might have occurred during laparoscopy. Third, ovarian preservation in a premenopausal woman with macroscopically normal ovaries reflected a patient-centered approach, avoiding unnecessary premature menopause. Fourth, the shared decision-making process regarding postoperative hormonal management and the structured surveillance protocol ensured both patient autonomy and clinical safety. Limitations Several limitations should be acknowledged. Preoperatively, the possibility of endometriosis was not sufficiently entertained due to the absence of classic symptoms, which delayed consideration of this diagnosis. While diagnostic laparoscopy was deemed high-risk given the imaging findings, its potential role could have been discussed more explicitly in the preoperative planning. Postoperatively, the decision to defer hormonal suppression, though supported by complete surgical resection and patient preference, was based on a single case; the true recurrence risk without hormonal therapy in omental endometriosis remains unknown. Additionally, the 12-month follow-up period, while reassuring, is relatively short given the chronic nature of endometriosis; longer surveillance is necessary to confirm the durability of this management strategy. Finally, frozen section examination during surgery could have been utilized to confirm the benign nature of the omental lesion intraoperatively, potentially guiding the extent of resection more precisely. Conclusions In conclusion, since the severity and atypical clinical presentations of endometriosis is often underestimated in routine clinical practice, it should be considered whether it is due to endometriosis if a woman of childbearing age — especially premenopausal women with no classic endometriosis symptoms and no predisposing factors for pelvic effusion — is found to suffer from significant hemorrhagic ascites after excluding other common causes of ascites. Mild to moderate elevation of CA125 with normal HE4 can be used as a key serological clue for the differential diagnosis of omental endometriosis and ovarian cancer. Additionally, women with a history of endometriosis should undergo regular re-examinations, and malignant transformation should be considered to avoid delaying treatment if rapid growth of lesions is detected. This case enriches the atypical clinical spectrum of omental endometriosis and demonstrates that this entity can present with isolated menstrual abnormalities and de novo pelvic encapsulated effusion, without classic symptoms or predisposing factors. The CA125-HE4 discordance pattern, negative ascitic cytology, and normal ovarian imaging constitute key preoperative clues for differentiating from malignancy.